Weekly round up from Life Sciences Industry.
Shanghai-based medical AI startup Synyi announced that it has raised RMB 250M ($36.3M) in Series C funding led by Chinese tech giant Tencent. Founded in 2016, Synyi started with Natural Language Processing (NLP) capabilities in the Chinese language and focused on hospitals? demand for scientific research data, combining AI & HIT to create their first smart analytics platform.
Date: July 15, 2019
Source: Telezkope
Sign up for DistilINFO e-Newsletters.
Bigfoot Biomedical Caps off its Series C Funding at $55M, Including a New $10M Addition
Sonde Health Acquires NeuroLex Lab’s Voice-Based Survey Platform
Revolutionizing Healthcare | Mass General Brigham Teams with AvoMD
3 Trends Driving Healthcare Mergers & Acquisitions (M&A) Activity in 2020
Amgen Completes Acquisition of Otezla® (Apremilast)
Medicure Provides Update on Release of Holdback Funds from Apicore Sale
SUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing
Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe